Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy

BACKGROUND: Duchenne muscular dystrophy (DMD) is a fatal disease for which no cure is available. Clinical trials have shown to be largely underpowered due to inter‐individual variability and noisy outcome measures. The availability of biomarkers able to anticipate clinical benefit is highly needed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Signorelli, Mirko, Ayoglu, Burcu, Johansson, Camilla, Lochmüller, Hanns, Straub, Volker, Muntoni, Francesco, Niks, Erik, Tsonaka, Roula, Persson, Anja, Aartsma‐Rus, Annemieke, Nilsson, Peter, Al‐Khalili Szigyarto, Cristina, Spitali, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113516/
https://www.ncbi.nlm.nih.gov/pubmed/31881125
http://dx.doi.org/10.1002/jcsm.12517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113516/
https://www.ncbi.nlm.nih.gov/pubmed/31881125
http://dx.doi.org/10.1002/jcsm.12517

Ejemplares similares